PMC:7346000 / 0-853 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2","span":{"begin":0,"end":8},"obj":"Disease"},{"id":"3","span":{"begin":20,"end":43},"obj":"Disease"},{"id":"25","span":{"begin":256,"end":264},"obj":"Species"},{"id":"28","span":{"begin":102,"end":111},"obj":"Species"},{"id":"33","span":{"begin":113,"end":135},"obj":"Disease"},{"id":"34","span":{"begin":137,"end":145},"obj":"Disease"},{"id":"35","span":{"begin":160,"end":195},"obj":"Disease"},{"id":"36","span":{"begin":197,"end":201},"obj":"Disease"},{"id":"37","span":{"begin":278,"end":301},"obj":"Disease"},{"id":"38","span":{"begin":320,"end":328},"obj":"Disease"},{"id":"39","span":{"begin":340,"end":363},"obj":"Disease"},{"id":"40","span":{"begin":464,"end":472},"obj":"Disease"},{"id":"41","span":{"begin":489,"end":541},"obj":"Disease"},{"id":"42","span":{"begin":583,"end":606},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"tao:has_database_id","subj":"2","obj":"MESH:C000657245"},{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"MESH:D055732"},{"id":"A25","pred":"tao:has_database_id","subj":"25","obj":"Tax:9606"},{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"Tax:11309"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:C000657245"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"MESH:C000657245"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"MESH:D012128"},{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"MESH:D012128"},{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"MESH:D055732"},{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"MESH:C000657245"},{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"MESH:D055732"},{"id":"A40","pred":"tao:has_database_id","subj":"40","obj":"MESH:C000657245"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"MESH:D008171"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"MESH:D055732"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment\n\nAbstract\nLike severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until June 2020. The release of danger-associated molecular patterns during severe COVID-19 results in both pulmonary epithelial damage and inflammatory disease, which are predisposing risk factors for pulmonary aspergillosis. Moreover, collateral effects of host recognition pathways required for the activation of antiviral immunity may, paradoxically, contribute to a highly permissive inflammatory environment that favors fungal pathogenesis. Diagnosis of CAPA remains"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"Disease"},{"id":"T2","span":{"begin":30,"end":43},"obj":"Disease"},{"id":"T3","span":{"begin":45,"end":49},"obj":"Disease"},{"id":"T4","span":{"begin":102,"end":111},"obj":"Disease"},{"id":"T5","span":{"begin":137,"end":145},"obj":"Disease"},{"id":"T6","span":{"begin":160,"end":195},"obj":"Disease"},{"id":"T7","span":{"begin":166,"end":195},"obj":"Disease"},{"id":"T8","span":{"begin":197,"end":201},"obj":"Disease"},{"id":"T9","span":{"begin":288,"end":301},"obj":"Disease"},{"id":"T10","span":{"begin":320,"end":328},"obj":"Disease"},{"id":"T11","span":{"begin":350,"end":363},"obj":"Disease"},{"id":"T12","span":{"begin":365,"end":369},"obj":"Disease"},{"id":"T13","span":{"begin":464,"end":472},"obj":"Disease"},{"id":"T14","span":{"begin":521,"end":541},"obj":"Disease"},{"id":"T15","span":{"begin":593,"end":606},"obj":"Disease"},{"id":"T16","span":{"begin":841,"end":845},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"}],"text":"COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment\n\nAbstract\nLike severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until June 2020. The release of danger-associated molecular patterns during severe COVID-19 results in both pulmonary epithelial damage and inflammatory disease, which are predisposing risk factors for pulmonary aspergillosis. Moreover, collateral effects of host recognition pathways required for the activation of antiviral immunity may, paradoxically, contribute to a highly permissive inflammatory environment that favors fungal pathogenesis. Diagnosis of CAPA remains"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":203,"end":206},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T2","span":{"begin":308,"end":310},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T3","span":{"begin":499,"end":509},"obj":"http://purl.obolibrary.org/obo/CL_0000066"},{"id":"T4","span":{"begin":683,"end":693},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T5","span":{"begin":750,"end":751},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment\n\nAbstract\nLike severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until June 2020. The release of danger-associated molecular patterns during severe COVID-19 results in both pulmonary epithelial damage and inflammatory disease, which are predisposing risk factors for pulmonary aspergillosis. Moreover, collateral effects of host recognition pathways required for the activation of antiviral immunity may, paradoxically, contribute to a highly permissive inflammatory environment that favors fungal pathogenesis. Diagnosis of CAPA remains"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":697,"end":706},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment\n\nAbstract\nLike severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until June 2020. The release of danger-associated molecular patterns during severe COVID-19 results in both pulmonary epithelial damage and inflammatory disease, which are predisposing risk factors for pulmonary aspergillosis. Moreover, collateral effects of host recognition pathways required for the activation of antiviral immunity may, paradoxically, contribute to a highly permissive inflammatory environment that favors fungal pathogenesis. Diagnosis of CAPA remains"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":814,"end":826},"obj":"http://purl.obolibrary.org/obo/GO_0009405"}],"text":"COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment\n\nAbstract\nLike severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until June 2020. The release of danger-associated molecular patterns during severe COVID-19 results in both pulmonary epithelial damage and inflammatory disease, which are predisposing risk factors for pulmonary aspergillosis. Moreover, collateral effects of host recognition pathways required for the activation of antiviral immunity may, paradoxically, contribute to a highly permissive inflammatory environment that favors fungal pathogenesis. Diagnosis of CAPA remains"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":166,"end":186},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment\n\nAbstract\nLike severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until June 2020. The release of danger-associated molecular patterns during severe COVID-19 results in both pulmonary epithelial damage and inflammatory disease, which are predisposing risk factors for pulmonary aspergillosis. Moreover, collateral effects of host recognition pathways required for the activation of antiviral immunity may, paradoxically, contribute to a highly permissive inflammatory environment that favors fungal pathogenesis. Diagnosis of CAPA remains"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":79},"obj":"Sentence"},{"id":"T2","span":{"begin":81,"end":89},"obj":"Sentence"},{"id":"T3","span":{"begin":90,"end":397},"obj":"Sentence"},{"id":"T4","span":{"begin":398,"end":607},"obj":"Sentence"},{"id":"T5","span":{"begin":608,"end":827},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment\n\nAbstract\nLike severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until June 2020. The release of danger-associated molecular patterns during severe COVID-19 results in both pulmonary epithelial damage and inflammatory disease, which are predisposing risk factors for pulmonary aspergillosis. Moreover, collateral effects of host recognition pathways required for the activation of antiviral immunity may, paradoxically, contribute to a highly permissive inflammatory environment that favors fungal pathogenesis. Diagnosis of CAPA remains"}